NEW  YORK (GenomeWeb News) - Daiichi Pure Chemicals, Toshiba, and Toshiba Hokuto Electronics plan to co-develop microarray-based in vitro diagnostic systems and chips, the companies said today.
 
Under the agreement, the companies will first develop an IVD for human papilloma virus.
 
Daiichi Pure Chemicals and Toshiba have collaborated on the system since January 2004.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.